![]() |
|||||||
|
Fusion Protein:KIF5B-HERC4 |
Fusion Gene and Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: KIF5B-HERC4 | FusionPDB ID: 42728 | FusionGDB2.0 ID: 42728 | Hgene | Tgene | Gene symbol | KIF5B | HERC4 | Gene ID | 3799 | 26091 |
Gene name | kinesin family member 5B | HECT and RLD domain containing E3 ubiquitin protein ligase 4 | |
Synonyms | HEL-S-61|KINH|KNS|KNS1|UKHC | - | |
Cytomap | 10p11.22 | 10q21.3 | |
Type of gene | protein-coding | protein-coding | |
Description | kinesin-1 heavy chainconventional kinesin heavy chainepididymis secretory protein Li 61kinesin 1 (110-120kD)kinesin heavy chainubiquitous kinesin heavy chain | probable E3 ubiquitin-protein ligase HERC4HECT domain and RCC1-like domain-containing protein 4HECT-type E3 ubiquitin transferase HERC4hect domain and RLD 4 | |
Modification date | 20200313 | 20200327 | |
UniProtAcc | P33176 Main function of 5'-partner protein: FUNCTION: Microtubule-dependent motor required for normal distribution of mitochondria and lysosomes. Can induce formation of neurite-like membrane protrusions in non-neuronal cells in a ZFYVE27-dependent manner (By similarity). Regulates centrosome and nuclear positioning during mitotic entry. During the G2 phase of the cell cycle in a BICD2-dependent manner, antagonizes dynein function and drives the separation of nuclei and centrosomes (PubMed:20386726). Required for anterograde axonal transportation of MAPK8IP3/JIP3 which is essential for MAPK8IP3/JIP3 function in axon elongation (By similarity). Through binding with PLEKHM2 and ARL8B, directs lysosome movement toward microtubule plus ends (Probable). Involved in NK cell-mediated cytotoxicity. Drives the polarization of cytolytic granules and microtubule-organizing centers (MTOCs) toward the immune synapse between effector NK lymphocytes and target cells (PubMed:24088571). {ECO:0000250|UniProtKB:Q2PQA9, ECO:0000250|UniProtKB:Q61768, ECO:0000269|PubMed:20386726, ECO:0000269|PubMed:24088571, ECO:0000305|PubMed:22172677, ECO:0000305|PubMed:24088571}. | Q5GLZ8 Main function of 5'-partner protein: FUNCTION: Probable E3 ubiquitin-protein ligase involved in either protein trafficking or in the distribution of cellular structures. Required for spermatozoon maturation and fertility, and for the removal of the cytoplasmic droplet of the spermatozoon. E3 ubiquitin-protein ligases accept ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfer it to targeted substrates. {ECO:0000250|UniProtKB:Q6PAV2}. | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000302418, ENST00000493889, | ENST00000395187, ENST00000480158, ENST00000492996, ENST00000277817, ENST00000373700, ENST00000395198, ENST00000412272, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 12 X 17 X 10=2040 | 5 X 5 X 3=75 |
# samples | 22 | 5 | |
** MAII score | log2(22/2040*10)=-3.2129937233342 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/75*10)=-0.584962500721156 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Fusion gene context | PubMed: KIF5B [Title/Abstract] AND HERC4 [Title/Abstract] AND fusion [Title/Abstract] | ||
Fusion neoantigen context | PubMed: KIF5B [Title/Abstract] AND HERC4 [Title/Abstract] AND neoantigen [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | KIF5B(32337392)-HERC4(69726559), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | KIF5B-HERC4 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. KIF5B-HERC4 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. KIF5B-HERC4 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. KIF5B-HERC4 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | KIF5B | GO:0042391 | regulation of membrane potential | 19675065 |
Hgene | KIF5B | GO:0043268 | positive regulation of potassium ion transport | 19675065 |
Hgene | KIF5B | GO:0047496 | vesicle transport along microtubule | 28426968 |
Hgene | KIF5B | GO:1903078 | positive regulation of protein localization to plasma membrane | 19675065 |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr10:32337392/chr10:69726559) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Amino Acid Sequences |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000302418 | KIF5B | chr10 | 32337392 | - | ENST00000277817 | HERC4 | chr10 | 69726559 | - | 3063 | 672 | 594 | 2039 | 481 |
ENST00000302418 | KIF5B | chr10 | 32337392 | - | ENST00000412272 | HERC4 | chr10 | 69726559 | - | 2829 | 672 | 594 | 1805 | 403 |
ENST00000302418 | KIF5B | chr10 | 32337392 | - | ENST00000395198 | HERC4 | chr10 | 69726559 | - | 3063 | 672 | 594 | 2039 | 481 |
ENST00000302418 | KIF5B | chr10 | 32337392 | - | ENST00000373700 | HERC4 | chr10 | 69726559 | - | 2458 | 672 | 594 | 2015 | 473 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000302418 | ENST00000277817 | KIF5B | chr10 | 32337392 | - | HERC4 | chr10 | 69726559 | - | 0.000254382 | 0.99974567 |
ENST00000302418 | ENST00000412272 | KIF5B | chr10 | 32337392 | - | HERC4 | chr10 | 69726559 | - | 0.000235208 | 0.99976474 |
ENST00000302418 | ENST00000395198 | KIF5B | chr10 | 32337392 | - | HERC4 | chr10 | 69726559 | - | 0.000254382 | 0.99974567 |
ENST00000302418 | ENST00000373700 | KIF5B | chr10 | 32337392 | - | HERC4 | chr10 | 69726559 | - | 0.000277872 | 0.99972206 |
![]() |
Get the fusion protein sequences from here. |
Fusion protein sequence information is available in the fasta format. >FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP |
Top |
Fusion Protein Breakpoint Sequences for KIF5B-HERC4 |
![]() |
Hgene | Hchr | Hbp | Tgene | Tchr | Tbp | Length(fusion protein) | BP in fusion protein | Peptide |
KIF5B | chr10 | 32337392 | HERC4 | chr10 | 69726559 | 672 | 23 | HLKSKCIMTVQRRLLKVNEKMGQIIQ |
Top |
Potential FusionNeoAntigen Information of KIF5B-HERC4 in HLA I |
![]() |
KIF5B-HERC4_32337392_69726559.msa |
![]() * We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5) |
Fusion gene | Hchr | Hbp | Tgene | Tchr | Tbp | HLA I | FusionNeoAntigen peptide | Binding score | Immunogenic score | Neoantigen start (at BP 13) | Neoantigen end (at BP 13) |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 | HLA-B52:01 | VQRRLLKV | 0.8609 | 0.6742 | 9 | 17 |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 | HLA-B27:05 | RRLLKVNEK | 0.9994 | 0.9169 | 11 | 20 |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 | HLA-B27:04 | RRLLKVNEK | 0.996 | 0.709 | 11 | 20 |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 | HLA-A32:13 | RLLKVNEKM | 0.9218 | 0.8732 | 12 | 21 |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 | HLA-A02:60 | RLLKVNEKM | 0.835 | 0.5347 | 12 | 21 |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 | HLA-A02:67 | RLLKVNEKM | 0.8318 | 0.5734 | 12 | 21 |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 | HLA-A02:30 | RLLKVNEKM | 0.8318 | 0.5734 | 12 | 21 |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 | HLA-A02:24 | RLLKVNEKM | 0.8318 | 0.5734 | 12 | 21 |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 | HLA-A02:04 | RLLKVNEKM | 0.8059 | 0.5289 | 12 | 21 |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 | HLA-A02:20 | RLLKVNEKM | 0.635 | 0.5758 | 12 | 21 |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 | HLA-A02:29 | RLLKVNEKM | 0.6323 | 0.582 | 12 | 21 |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 | HLA-B13:02 | RLLKVNEKM | 0.0149 | 0.5675 | 12 | 21 |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 | HLA-B13:01 | RLLKVNEKM | 0.0101 | 0.9385 | 12 | 21 |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 | HLA-B27:02 | RRLLKVNEKM | 0.9999 | 0.6553 | 11 | 21 |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 | HLA-B27:04 | RRLLKVNEKM | 0.9999 | 0.7133 | 11 | 21 |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 | HLA-B27:05 | RRLLKVNEKM | 0.9999 | 0.9201 | 11 | 21 |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 | HLA-B27:14 | RRLLKVNEK | 0.999 | 0.8143 | 11 | 20 |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 | HLA-B27:03 | RRLLKVNEK | 0.978 | 0.9308 | 11 | 20 |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 | HLA-A02:01 | RLLKVNEKM | 0.8318 | 0.5734 | 12 | 21 |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 | HLA-B27:14 | RRLLKVNEKM | 0.9999 | 0.8343 | 11 | 21 |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 | HLA-B27:03 | RRLLKVNEKM | 0.9984 | 0.9365 | 11 | 21 |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 | HLA-B27:10 | RRLLKVNEK | 0.9991 | 0.8405 | 11 | 20 |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 | HLA-B27:08 | RRLLKVNEK | 0.9988 | 0.8015 | 11 | 20 |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 | HLA-A30:01 | MTVQRRLLK | 0.994 | 0.6843 | 7 | 16 |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 | HLA-C15:02 | TVQRRLLKV | 0.9905 | 0.8131 | 8 | 17 |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 | HLA-C15:05 | TVQRRLLKV | 0.9875 | 0.8676 | 8 | 17 |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 | HLA-A32:01 | RLLKVNEKM | 0.974 | 0.9112 | 12 | 21 |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 | HLA-B15:73 | RLLKVNEKM | 0.2786 | 0.8343 | 12 | 21 |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 | HLA-B15:30 | RLLKVNEKM | 0.1487 | 0.7625 | 12 | 21 |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 | HLA-B27:08 | RRLLKVNEKM | 0.9999 | 0.8072 | 11 | 21 |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 | HLA-B27:10 | RRLLKVNEKM | 0.9999 | 0.8602 | 11 | 21 |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 | HLA-B27:06 | RRLLKVNEKM | 0.9997 | 0.6908 | 11 | 21 |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 | HLA-B27:09 | RRLLKVNEKM | 0.999 | 0.9104 | 11 | 21 |
Top |
Potential FusionNeoAntigen Information of KIF5B-HERC4 in HLA II |
![]() |
KIF5B-HERC4_32337392_69726559.msa |
![]() * We used NetMHCIIpan v4.1 (%rank<0.5). |
Fusion gene | Hchr | Hbp | Tgene | Tchr | Tbp | HLA II | FusionNeoAntigen peptide | Neoantigen start (at BP 13) | Neoantigen end (at BP 13) |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 | DRB1-0324 | RRLLKVNEKMGQIIQ | 11 | 26 |
Top |
Fusion breakpoint peptide structures of KIF5B-HERC4 |
![]() * The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA. |
File name | BPseq | Hgene | Tgene | Hchr | Hbp | Tchr | Tbp | AAlen |
3844 | IMTVQRRLLKVNEK | KIF5B | HERC4 | chr10 | 32337392 | chr10 | 69726559 | 672 |
Top |
Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of KIF5B-HERC4 |
![]() * We used Glide to predict the interaction between HLAs and neoantigens. |
HLA allele | PDB ID | File name | BPseq | Docking score | Glide score |
HLA-B14:02 | 3BVN | 3844 | IMTVQRRLLKVNEK | -6.12283 | -6.12283 |
HLA-A24:02 | 5HGA | 3844 | IMTVQRRLLKVNEK | -7.36995 | -7.36995 |
Top |
Vaccine Design for the FusionNeoAntigens of KIF5B-HERC4 |
![]() |
Fusion gene | Hchr | Hbp | Tchr | Tbp | Start in +/-13AA | End in +/-13AA | FusionNeoAntigen peptide sequence | FusionNeoAntigen RNA sequence |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 11 | 20 | RRLLKVNEK | TTAAAGGTAAATGAGAAAATGGGACAG |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 11 | 21 | RRLLKVNEKM | TTAAAGGTAAATGAGAAAATGGGACAGATT |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 12 | 21 | RLLKVNEKM | AAGGTAAATGAGAAAATGGGACAGATT |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 7 | 16 | MTVQRRLLK | CAAAGAAGATTGTTAAAGGTAAATGAG |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 8 | 17 | TVQRRLLKV | AGAAGATTGTTAAAGGTAAATGAGAAA |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 9 | 17 | VQRRLLKV | AGATTGTTAAAGGTAAATGAGAAA |
![]() |
Fusion gene | Hchr | Hbp | Tchr | Tbp | Start in +/-13AA | End in +/-13AA | FusionNeoAntigen peptide | FusionNEoAntigen RNA sequence |
KIF5B-HERC4 | chr10 | 32337392 | chr10 | 69726559 | 11 | 26 | RRLLKVNEKMGQIIQ | TTAAAGGTAAATGAGAAAATGGGACAGATTATACAGTATGATAAA |
Top |
Information of the samples that have these potential fusion neoantigens of KIF5B-HERC4 |
![]() |
Cancer type | Fusion gene | Hchr | Hbp | Henst | Tchr | Tbp | Tenst | Sample |
STAD | KIF5B-HERC4 | chr10 | 32337392 | ENST00000302418 | chr10 | 69726559 | ENST00000277817 | TCGA-HU-A4HB-01A |
Top |
Potential target of CAR-T therapy development for KIF5B-HERC4 |
![]() |
![]() * Minus value of BPloci means that the break point is located before the CDS. |
- In-frame and retained 'Transmembrane'. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
![]() * We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image. |
Hgene | Hchr | Hbp | Henst | Tgene | Tchr | Tbp | Tenst | DeepLoc result |
Top |
Related Drugs to KIF5B-HERC4 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to KIF5B-HERC4 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | KIF5B | C0007131 | Non-Small Cell Lung Carcinoma | 1 | CTD_human |
Hgene | KIF5B | C0011849 | Diabetes Mellitus | 1 | CTD_human |